A Randomized, Open-label, Single, 2x2 Crossover Study to Compare the Safety and Pharmacokinetics of "CG1801" and "CGL1802" in Healthy Volunteers
Latest Information Update: 26 Sep 2019
At a glance
- Drugs Polmacoxib (Primary)
- Indications Osteoarthritis
- Focus Pharmacokinetics
- Sponsors CrystalGenomics
- 23 Sep 2019 Status changed from recruiting to completed.
- 29 Jan 2019 Status changed from not yet recruiting to recruiting.
- 19 Dec 2018 New trial record